Le Lézard
Classified in: Covid-19 virus
Subjects: Product/Service, Economic News/Analysis

Best's Special Report: U.S. Life/Health Credit Rating Upgrades Outnumber Downgrades in First-Half 2020


The U.S. life/health industry saw more credit rating upgrades than downgrades in first-half 2020, driven primarily by improved levels of risk-adjusted capitalization. However, according to a new AM Best special report, negative rating actions could increase in the second half of the year as the COVID-19 pandemic negatively impacts companies' sales, operations, operating performance and investments.

The Best's Special Report, titled, "Life/Health Upgrades Outnumber Downgrades in First-Half 2020," states that AM Best upgraded the Long-Term Issuer Credit Ratings of 12 rating units and downgraded four among life/annuity (L/A) and health carriers in the first half of 2020, compared with 15 upgrades and four downgrades in the first half of 2019. Upgrades were more concentrated in the L/A segment, which reported eight upgrades. Nearly 80% of rating actions in first-half of 2020 were affirmations, consistent with most years.

Positive rating developments for L/A/ carriers was mostly due to increased strategic value, stronger risk-adjusted capitalization and improved enterprise risk management practices. For health insurers increased strategic value of business diversification of a subsidiary relative to the group, as well as improvement in capitalization and earnings led to positive rating developments. Other report highlights include rating units that were placed under review, details on specific rating activity, as well as updates on rating outlooks.

AM Best revised its market segment outlook on the U.S. L/A segment to negative from stable in April 2020, primarily based on the impact of the COVID-19 pandemic. Operating performance is expected to deteriorate in the near to medium term amid the anticipated dislocation of assets and liabilities. AM Best maintains a stable outlook on the U.S. health industry segment, despite the wide impact of COVID-19. Key factors include lower utilization trends driven by the deferral of visits for routine care and elective procedures, a trend of strong earnings and strengthened risk-adjusted capitalization through year-end 2019.

To access the full copy of this special report, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=301570.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in New York, London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2020 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.


These press releases may also interest you

at 02:30
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:05
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2024. "All outstanding major construction at our QB operation was completed in the first quarter, including the shiploader and molybdenum plant, and we marked the...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...



News published on and distributed by: